active pharma ingredients

Rakesh Jhunjhunwala firm-backed Concord Biotech files for IPO

Late billionaire investor Rakesh Jhunjhunwala's firm Rare Enterprises-backed Concord Biotech has filed its draft red herring prospectus (DRHP) with capital ......

• Staff Writer